Durham, NC (PRWEB) September 26, 2013
Cato Research (CATO), a global contract research organization, is pleased to announce the recent hire of Benjamin Alt and Kris Dyszynski. They are welcomed aboard CATO’s international commercial team, increasing CATO’s ability to provide greater, personalized services to its clients.
Benjamin Alt, M.B.A., M.Sc., joins as a bilingual business development professional in the Montreal office. Alt brings years of regulatory affairs expertise and clinical marketing experience to the CATO team. He has a proven record of drug development management, including work with a portfolio that includes several orphan drugs, an exciting area in which CATO has known expertise.
Kris Dyszynski, B.A., joins CATO as a business development professional in the San Diego office. Dyszynski has extensive years of biotechnology and pharmaceutical consulting experience. He has strategic and tactical expertise in developing key industry programs, including grant collaborations, as well as a depth of experience in many therapeutic areas. These important attributes will ensure added value to the CATO group and its clients.
“The addition of Ben and Kris represents an important landmark in our increased ability to provide current and new clients with more experienced and focused relationship management and oversight of strategic alliance partnerships. These team members also offer significant experience in the life science investment sector supporting Cato BioVentures’ various funding models to help our clients and partners advance their programs through the clinic, toward market, or to their partnering objectives. The caliber and competencies of Ben and Kris will match the caliber and competencies of our scientific, regulatory, and clinical teams, enhancing CATO’s reputation for solid, reliable, and trusted services. I am really excited about their joining our commercial team and working with two talented and experienced businessmen,” says David Gee, Strategic Business Developer.
About Cato Research
Founded in 1988 by Dr. Allen Cato and Lynda Sutton and headquartered near Research Triangle Park, North Carolina, Cato Research is a full-service, global contract research and development organization providing strategic and tactical support for clients in the pharmaceutical, biotechnology, and medical device industries. Services range from design and management of preclinical and clinical studies to submission of regulatory documents required for marketing approval. With a staff of approximately 300 and offices located in the United States, Europe, Canada, Israel, and South Africa, the Cato Research team consistently demonstrates an unsurpassed level of responsiveness, flexibility, attention to detail, and passion for bringing their clients’ products to market with speed and cost-effectiveness.
For more information, please contact:
# # #